Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 6/20 | 0.58 |
| ▸ | NAALAD2 | Q9Y3Q0 | 4/20 | 0.58 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.58 |
| ▸ | GRM8 | O00222 | 1/20 | 0.48 |
| ▸ | GRM6 | O15303 | 1/20 | 0.48 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.48 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.48 |
| ▸ | GSR | P00390 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.48 |
| ▸ | GRM5 | P41594 | 1/20 | 0.48 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.48 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.48 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.48 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.48 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.48 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29352444 | 1.00 | FOLH1 (0.58) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL29539765 | 0.97 | FOLH1 (0.55) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL30193339 | 0.95 | FOLH1 (0.53) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL30193271 | 0.95 | FOLH1 (0.53) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL30040038 | 0.95 | FOLH1 (0.53) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL28464431 | 0.94 | FOLH1 (0.51) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL30040249 | 0.94 | FOLH1 (0.51) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL28464429 | 0.94 | FOLH1 (0.51) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL29873398 | 0.92 | FOLH1 (0.49) | FOLH1NAALAD2RIMKLAGRM8GRM6 | |
| SCHEMBL28686678 | 0.91 | FOLH1 (0.49) | FOLH1NAALAD2RIMKLAGRM8GRM6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118759175-B | Immunoglobulin G4 subtype detection kit and preparation method thereof | 浙江伊利康生物技术有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-118759175-A | Immunoglobulin G4 subtype detection kit and preparation method thereof | 浙江伊利康生物技术有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-116987142-A | Composition containing gamma-aminobutyric acid and alkaline probiotics active peptide and application of composition in preparation of product with anti-aging effect | 深圳海创生物科技有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-116847882-A | HIV vaccine and methods of use thereof | 吉利德科学公司 | 2023-10-03 | — | — | CN | claimed |
| CN-116106271-A | Method for screening umami peptide | 上海市农业科学院 | 2023-05-12 | — | — | CN | claimed |
| CN-118759175-B | Immunoglobulin G4 subtype detection kit and preparation method thereof | 浙江伊利康生物技术有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119530123-A | Low-sodium salt-reducing and freshness-increasing metaplasia and preparation method and application thereof | 内蒙古科拓生物有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-118759175-A | Immunoglobulin G4 subtype detection kit and preparation method thereof | 浙江伊利康生物技术有限公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-118207280-A | Pigeon meat flavor peptide screening and study on flavor development mechanism of pigeon meat flavor peptide and receptor T1R1-T1R3 | 渤海大学 | 2024-06-18 | — | — | CN | disclosed |
| US-20240165239-A1 | Covalent Binding Compounds for the Treatment of Disease | HYKU BIOSCIENCES INC. (US) | 2024-05-23 | — | — | US | disclosed |
| CN-117677302-A | Peptide compounds for flavor modulation | CJ第一制糖株式会社 | 2024-03-08 | — | — | CN | disclosed |
| US-11911451-B2 | Composition of tumor-associated proliferative peptides and related anti-cancer immunogen for the treatment of lung cancers and other cancers | ImmuLogix Ltd (US) | 2024-02-27 | — | — | US | disclosed |
| EP-4301359-A1 | COVALENT BINDING COMPOUNDS FOR THE TREATMENT OF DISEASE | Umbra Therapeutics Inc. (US) | 2024-01-10 | — | — | EP | disclosed |
| CN-116987142-A | Composition containing gamma-aminobutyric acid and alkaline probiotics active peptide and application of composition in preparation of product with anti-aging effect | 深圳海创生物科技有限公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-116987142-A | Composition containing gamma-aminobutyric acid and alkaline probiotics active peptide and application of composition in preparation of product with anti-aging effect | 深圳海创生物科技有限公司 | 2023-11-03 | — | — | CN | disclosed |
| US-20230303626-A1 | MACROCYCLIC POLYPEPTIDES | UNIVERSITY OF WASHINGTON | 2023-09-28 | — | — | US | disclosed |
| CN-116106271-A | Method for screening umami peptide | 上海市农业科学院 | 2023-05-12 | — | — | CN | disclosed |
| US-11524979-B2 | Macrocyclic polypeptides | UNIVERSITY OF WASHINGTON (US) | 2022-12-13 | — | — | US | disclosed |
| WO-2022187690-A1 | COVALENT BINDING COMPOUNDS FOR THE TREATMENT OF DISEASE | UMBRA THERAPEUTICS INC. (US) | 2022-09-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240165239-A1 | Covalent Binding Compounds for the Treatment of Disease | SSB, PTMS, CD2BP2 | FOLH1 1886/4885NAALAD2 374/4885RIMKLA 2631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.